why choose us

First received: June 28, 2023

Clinical Trial: A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Migraine

Study Type: OBSERVATIONAL


Official Title: A Prospective, Open-label, Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention in Real-world Environment.

Brief Summary: Nerivio is a remote electrical neuromodulation (REN) device that is FDA-cleared for migraine prevention (as well as for acute treatment of migraine), in individuals 12 and older.The study is a post-marketing, observational, prospective, real-world evidence study assessing the safety, efficacy, and health economics outcomes of Nerivio for migraine prevention in a real-world environment.The study population is naïve Nerivio users, aged 12 and up, who were prescribed Nerivio by their healthcare provider for either…

Read more